SOCIAL MEDIA IN THE PHARMACEUTICAL INDUSTRY

During this period of uncertainty in social media engagement for the pharmaceutical industry, AstraZeneca sought feedback on our submission to the Food and Drug Administration (FDA) Call for Comments—not from the FDA—but from a variety of active participants in social media. This white paper is a report of this feedback and provides unique insights into the beliefs of various stakeholders about how pharmaceutical manufacturers have engaged in social media and how they should engaged.
Read more...

;